JP Morgan Private Wealth Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.86M Sell
129,379
-1,564
-1% -$24.4K 0.01% 760
2023
Q2
$2.15M Sell
130,943
-10,835
-8% -$177K 0.01% 541
2023
Q1
$2.37M Sell
141,778
-22,299
-14% -$359K 0.01% 818
2022
Q4
$2.53M Sell
164,077
-39,835
-20% -$617K 0.01% 768
2022
Q3
$3.04M Buy
203,912
+80,299
+65% +$1.33M 0.01% 706
2022
Q2
$2.03M Buy
123,613
+245
+0.2% +$4.2K 0.01% 843
2022
Q1
$2.48M Buy
+123,368
New +$2.56M 0.01% 829
2021
Q1
Sell
-21,400
Closed -$613K 1753
2020
Q4
$613K Buy
+21,400
New +$569K ﹤0.01% 1210

Other funds holding BMEZ

JP Morgan Private Wealth Advisors's BMEZ Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors reduced its BlackRock Health Sciences Trust II (BMEZ) stake by 1.2% in Q3 2023, selling an estimated $24.4K and leaving 129,379 shares worth $1.86M. The position accounts for 0.01% of the portfolio, ranked #760.

JP Morgan Private Wealth Advisors first reported a position in BMEZ in Q4 2020 and has held it in 8 quarters since. The position peaked at $3.04M in Q3 2022. 98 funds tracked by Wall St. Rank hold BMEZ as of Q3 2023.

  • JP Morgan Private Wealth Advisors held 129,379 shares of BlackRock Health Sciences Trust II worth $1.86M as of Q3 2023.
  • JP Morgan Private Wealth Advisors sold 1,564 BlackRock Health Sciences Trust II shares in Q3 2023, an estimated $24.4K.
  • BlackRock Health Sciences Trust II made up 0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #760 holding.
  • JP Morgan Private Wealth Advisors first reported a position in BlackRock Health Sciences Trust II in Q4 2020 and has held it in 8 quarters since.
  • JP Morgan Private Wealth Advisors's BlackRock Health Sciences Trust II position peaked at $3.04M in Q3 2022.
  • 98 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.